Related Experiment Videos
Simple risk predictions for arteriovenous malformation hemorrhage
D Kondziolka1, M R McLaughlin, J R Kestle
1Department of Neurological Surgery, Presbyterian University Hospital, University of Pittsburgh, Pennsylvania, USA.
Neurosurgery
|November 1, 1995
Summary
A new formula simplifies predicting arteriovenous malformation hemorrhage risk. This tool helps neurosurgeons estimate long-term bleeding probability for patients with brain arteriovenous malformations, improving clinical decision-making.
Area of Science:
- Neurosurgery
- Biostatistics
- Medical Informatics
Background:
- Brain arteriovenous malformations (AVMs) carry an annual hemorrhage risk of 2-4%.
- Existing decision analysis programs and biostatistical models for predicting AVM hemorrhage risk are complex.
- Neurosurgical community's knowledge and use of these risk prediction tools vary.
Purpose of the Study:
- To develop a simple, accessible risk prediction formula for arteriovenous malformation hemorrhage.
- To assess neurosurgeons' current understanding and methods for calculating long-term hemorrhage risk.
- To provide a practical alternative to complex biostatistical models for AVM risk assessment.
Main Methods:
- Survey conducted among neurosurgeons at national meetings in 1988 and 1994.
- Participants were asked to estimate hemorrhage risk over 20-30 years for young adults with a 3-4% annual risk.
- Utilized the multiplicative law of probability: Risk = 1 - (1 - annual risk)^(expected years of life).
Main Results:
- Survey revealed wide-ranging and inconsistent estimations of hemorrhage risk (1-100%) among neurosurgeons.
- Diverse calculation methods were employed, indicating a lack of standardized approach.
- The proposed simple formula provides consistent predictions across age groups when combined with survival data.
Conclusions:
- A simple multiplicative probability formula offers a reasonable and justifiable method for predicting brain AVM hemorrhage risk.
- This formula is a practical alternative for neurosurgeons lacking familiarity with complex biostatistical models.
- Standardizing risk prediction can improve patient management and decision-making for brain AVMs.